Detail akcie TERUMO online

Business Summary: TERUMO CORPORATION is a manufacturer of medical supplies. The Company operates in three segments. The Cardiac and Vascular Company segment is engaged in the manufacture of catheter system and cardiopulmonary system products, the import of the cardiopulmonary systems and artificial blood vessels, as well as the sale of products mainly to hospitals and clinics nationwide through agents. The Hospital Company segment is engaged in the manufacture, purchase and sale of hospital medical equipment, pharmaceuticals, peritoneal dialysis and diabetes related products, and the rental of hospital medical equipment and home medical products. The segment is also engaged in the manufacture and sale of healthcare related products. The Blood System Company segment is engaged in the manufacture and sale of blood transfusion-related products.
Financial Summary: BRIEF: For the nine months ended 31 December 2023, Terumo Corp revenues increased 11% to Y682.95B. Net income applicable to common stockholders increased 14% to Y79.9B. Revenues reflect Cardiovascular area business segment increase of 14% to Y407.7B, Blood system business segment increase of 13% to Y127.8B, Hospital business segment increase of 1% to Y147.28B, Americas segment increase of 12% to Y238.2B, Europe segment increase of 17% to Y139.02B.